Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Journal of the American Chemical Society|November 30, 2024
Bioorthogonal Activation of Deep Red Photoredox Catalysis Inducing PyroptosisJungryun Kim, Yunjie Xu, Jong Hyeon Lim, et al.
Bioconjugate Chemistry|June 2, 2016
Electrophilic, Activation-Free Fluorogenic Reagent for Labeling Bioactive AminesMiquel Sintes, Fabio De Moliner, David Caballero-Lima, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 19, 2024
Photosensitizer-Amplified Antimicrobial Materials for Broad-Spectrum Ablation of Resistant Pathogens in Ocular InfectionsCharles Lochenie, Sheelagh Duncan, Yanzi Zhou, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
Enzyme-Activatable Chemokine Conjugates for In Vivo Targeting of Tumor-Associated MacrophagesNicole D Barth, Floris J Van Dalen, Utsa Karmakar, et al.
Angewandte Chemie (International Ed. in English)|August 22, 2022
Enzyme-Activatable Chemokine Conjugates for In Vivo Targeting of Tumor-Associated MacrophagesNicole D Barth, Floris J Van Dalen, Utsa Karmakar, et al.
Biomedical Optics Express|August 14, 2025
Real-time detection of singlet-oxygen signatures using a single-photon avalanche diode detectorArran Sykes, Lisa Saalbach, Sam Benson, et al.
Biofabrication|August 2, 2019
3D bioprinting of mature bacterial biofilms for antimicrobial resistance drug testingEvita Ning, Gareth Turnbull, Jon Clarke, et al.
European Journal of Medicinal Chemistry|May 14, 2015
A solid-phase combinatorial approach for indoloquinolizidine-peptides with high affinity at D(1) and D(2) dopamine receptorsAnabel Molero, Marc Vendrell, Jordi Bonaventura, et al.
Chemmedchem|June 27, 2009
Indoloquinolizidine-peptide hybrids as multiple agonists for D1 and D2 dopamine receptorsMarc Vendrell, Aroa Soriano, Vicent Casadó, et al.
Pageof 13